Resultados de la búsqueda 651-660 of 16479 for multiple%20sclerosis

  1. Ensayos clínicos - Hematología

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  2. Mielitis transversa - Diagnóstico y tratamiento - Mayo Clinic

    National Multiple Sclerosis Society. https://www.nationalmssociety.org/What-is-MS/Related-Conditions/Transverse-Myelitis. Accessed Nov. 4, 2019 ...

  3. Ensayos clínicos - Neurología

    The purpose of this study is to develop a natural history dataset and biorepository of early Primary Lateral Sclerosis (PLS) and well-established PLS cases for ...

  4. Neurología - Ensayos clínicos

    This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...

  5. Ensayos clínicos - Neurología

    FTLD is a neurodegenerative disorder of the nervous system which there are no approved treatments or cures. The study has two arms: a “longitudinal arm” ...

  6. Neurología - Ensayos clínicos

    ... multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no ...

  7. Neurología - Ensayos clínicos

    There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). Early detection is ...

  8. Oncología (médica) - Ensayos clínicos

    Ensayos clínicos · A Study to Evaluate EAA181 to Treat Newly-diagnosed Multiple Myeloma · Circulating Tumor DNA (cTDNA) Based in NGS (Next Generation Sequencing) ...

  9. Neurología - Ensayos clínicos

    There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). Early detection is ...

  10. Neurocirugía - Ensayos clínicos

    ... multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no ...